✕
Login
Register
Back to News
MiNK Therapeutics Q4 EPS $(0.56) Beats $(0.82) Estimate
Benzinga Newsdesk
www.benzinga.com
Negative 64.4%
Neg 64.4%
Neu 0%
Pos 0%
Comments
No comments yet. Be the first!
Join the discussion
Login to comment
Login to comment